Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin.
about
Basaloid squamous cell carcinoma: two case reports.Ber-EP4, CK1, CK7 and CK14 are useful markers for basaloid squamous carcinoma: a study of 45 cases.Intraoral basal cell carcinoma, a rare neoplasm: report of three new cases with literature reviewPrognostic factors in patients with diffuse type gastric cancer (linitis plastica) after operative treatmentBasosquamous carcinoma of the head and neck: clinical and histologic characteristics and their impact on disease progression.The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathologyRole of mucins in the skin during benign and malignant conditions.Use of Ber-EP4 protein in recurrent metastatic basal cell carcinoma: a case report and review of the literature.Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An UpdateImmunohistochemistry in the diagnosis of cutaneous neoplasms.An update on nonmelanoma skin cancer.Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery.Basaloid Squamous Carcinoma of Skin Associated with Xeroderma Pigmentosum in an 8-year-old Child: A Rare Entity.Prognostic variables in high-risk cutaneous squamous cell carcinoma: a review.Use of Ber-EP4 and Epithelial Specific Antigen to Differentiate Clinical Simulators of Basal Cell Carcinoma.Metastatic basal cell carcinoma with loss of p63 and mismatch repair proteins.Clinicopathological analysis of basal cell carcinoma of the anal region and its distinction from basaloid squamous cell carcinoma.Metastatic basosquamous carcinoma detected by sentinel lymph node biopsy.CD117, CK20, TTF-1, and DNA topoisomerase II-alpha antigen expression in small cell tumors.Pigmented fibroepithelioma of Pinkus.Basosquamous carcinoma: is it an aggressive tumor?Metatypical Basal cell carcinomas: a successful surgical approach to two cases with different tumor locations.Sebaceous carcinoma associated with seborrheic keratosis.The Effects of Cyclin D1 and Bcl-2 Expressıon on Aggressive Behavior in Basal Cell and Basosquamous CarcinomaCD117 (KIT) is a useful immunohistochemical marker for differentiating porocarcinoma from squamous cell carcinoma.Limitations of Ber-EP4 for distinction of Bowen disease from basal cell carcinoma.Squamous cell carcinoma of the skin: dual differentiations to rare basosquamous and spindle cell variants.Metastatic Basosquamous Carcinoma: Report of Two Cases and Clinicopathological Considerations.Basal cell carcinoma: CD56 and cytokeratin 5/6 staining patterns in the differential diagnosis with Merkel cell carcinoma.Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.BerEP4 is widely expressed in tumors of the sweat apparatus: a source of potential diagnostic error.Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.Ber-EP4 enhances the differential diagnostic accuracy of cytokeratin 7 in pagetoid cutaneous neoplasms.The Use of BEREP4 Immunohistochemistry Staining for Detection of Basal Cell Carcinoma.Basosquamous Carcinoma: A Single Centre Clinicopathological Evaluation and Proposal of an Evidence-Based Protocol.Expression and glycosylation of MUC1 in epidermolysis bullosa-associated and sporadic cutaneous squamous cell carcinomas
P2860
Q33580599-715F543F-E17A-4E57-9297-9054D6E6DE3BQ33627858-8EE27B0D-DAB9-4873-88DB-70499B4D0E27Q34021228-531024E0-179A-4E85-9142-FDC0C3E55146Q34627153-A4FB46A8-9DA8-4323-8792-315DD2028855Q35214526-635769F5-88E1-41FF-B9A1-82A67AEB6B17Q35591389-FC9A25CA-5206-4ED3-BA4F-88D9CA975861Q35596376-ED92297F-1A5E-4907-B65E-D1FC433E47E4Q35860260-3D776922-9C55-4579-AC4C-37573E6CAB24Q36752423-28046B4D-8DFD-400E-A78F-5A394EC9A720Q37658770-63C71989-3145-4CBF-AC77-47BCCC48F2D1Q37851020-DBB0EE72-EC51-4ABC-82D0-5213A4F5F92FQ38222895-357F6E34-77B1-47E8-8C85-047CE0884E13Q38284874-B16FD8E2-7845-4E04-93DE-5FF8E004401FQ38893927-31D8E343-885A-46E1-A46A-E519596E4381Q42154694-6EC3FFBE-6CDB-4A30-A860-947824D1FFBDQ42181877-B218550D-2BDB-4FB5-9ED2-D4F4C3FF2723Q42437415-451309AC-A0F4-409C-9F2E-1FF386CC908EQ42439316-D5A9BC68-E0E3-44C3-8AF5-1A20838EE0F0Q42457652-4284EFA8-6DF2-482B-9611-BC2FCB75A971Q42463690-236CEC2E-A8B0-4765-AE53-DF179F47D11FQ42464246-3A5A15B0-F208-4714-B0EC-930FB90B0784Q42470934-BEB60340-EE7A-4057-B490-E1678816C0A4Q42477517-B5279C23-BFAA-442E-AD34-A40DB313C43BQ42482103-62EB9D7E-5984-4BBD-A7CE-30E00FEDF7F5Q42483468-8DD12133-D167-4107-8FA2-79C04B5AE526Q42487449-564F2D49-9F7B-43E6-BB3D-68C7FD20FB77Q42490592-ECF734E2-1490-4246-8FEE-B58FC5B78D70Q42493861-B6F2B2A9-3149-4537-B5AB-FA866E77B985Q42508427-49CCD15A-F459-4BBA-98AE-9E2CAB8CF773Q42514690-F7DBD789-C97D-42D4-B6A9-CD9C5451F8C1Q42516984-1B3E56FA-4C64-4E10-B257-6D75430C2BF4Q42519056-9193B486-2DF3-4AE8-A251-E303BE1F7850Q42520544-FCA0B43F-EC30-4986-AF31-BB6AEB71CD63Q42525659-EA94FEE8-465A-40A4-8801-1C63EE1D7872Q49787188-27DDF1E9-2EAD-499F-AB9F-614BCBB1ECCFQ55487190-78216872-930F-4E41-9FAE-BE5C490E434BQ58039395-073E0937-2F8A-4AA7-B8E5-0077BF91EB8D
P2860
Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Ber EP4 and epithelial membran ...... uamous carcinomas of the skin.
@en
type
label
Ber EP4 and epithelial membran ...... uamous carcinomas of the skin.
@en
prefLabel
Ber EP4 and epithelial membran ...... uamous carcinomas of the skin.
@en
P2093
P2860
P1433
P1476
Ber EP4 and epithelial membran ...... uamous carcinomas of the skin.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2559.2000.00999.X
P577
2000-09-01T00:00:00Z